These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

346 related items for PubMed ID: 22608952

  • 1. Meta-analysis of cardiovascular outcomes with dronedarone in patients with atrial fibrillation or heart failure.
    Chatterjee S, Ghosh J, Lichstein E, Aikat S, Mukherjee D.
    Am J Cardiol; 2012 Aug 15; 110(4):607-13. PubMed ID: 22608952
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of dronedarone: a review of randomized trials.
    Christiansen CB, Torp-Pedersen C, Køber L.
    Expert Opin Drug Saf; 2010 Jan 15; 9(1):189-99. PubMed ID: 20001756
    [Abstract] [Full Text] [Related]

  • 3. Rhythm- and rate-controlling effects of dronedarone in patients with atrial fibrillation (from the ATHENA trial).
    Page RL, Connolly SJ, Crijns HJ, van Eickels M, Gaudin C, Torp-Pedersen C, Hohnloser SH, ATHENA Investigators.
    Am J Cardiol; 2011 Apr 01; 107(7):1019-22. PubMed ID: 21296333
    [Abstract] [Full Text] [Related]

  • 4. An individual patient-based meta-analysis of the effects of dronedarone in patients with atrial fibrillation.
    Hohnloser SH, Connolly SJ, John Camm A, Halperin JL, Radzik D.
    Europace; 2014 Aug 01; 16(8):1117-24. PubMed ID: 24728270
    [Abstract] [Full Text] [Related]

  • 5. Dronedarone: an emerging therapy for atrial fibrillation.
    Rosei EA, Salvetti M.
    Ther Adv Cardiovasc Dis; 2010 Jun 01; 4(3):155-64. PubMed ID: 20418270
    [Abstract] [Full Text] [Related]

  • 6. Dronedarone therapy in atrial fibrillation: a summary of recent controlled trials.
    Duray GZ, Schmitt J, Hohnloser SH.
    J Cardiovasc Pharmacol Ther; 2010 Dec 01; 15(4 Suppl):19S-23S. PubMed ID: 20472812
    [Abstract] [Full Text] [Related]

  • 7. Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation.
    Piccini JP, Hasselblad V, Peterson ED, Washam JB, Califf RM, Kong DF.
    J Am Coll Cardiol; 2009 Sep 15; 54(12):1089-95. PubMed ID: 19744618
    [Abstract] [Full Text] [Related]

  • 8. A review of the appropriate and inappropriate use of dronedarone: lessons learned from controlled studies and regulatory submission.
    Naccarelli GV, Wolbrette DL, Samii S, Banchs JE, Penny-Peterson E, Gonzalez MD.
    J Cardiovasc Pharmacol Ther; 2010 Dec 15; 15(4 Suppl):24S-30S. PubMed ID: 21098416
    [Abstract] [Full Text] [Related]

  • 9. Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter.
    Connolly SJ, Crijns HJ, Torp-Pedersen C, van Eickels M, Gaudin C, Page RL, Hohnloser SH, ATHENA Investigators.
    Circulation; 2009 Sep 29; 120(13):1174-80. PubMed ID: 19752319
    [Abstract] [Full Text] [Related]

  • 10. Dronedarone or amiodarone for rhythm control for atrial fibrillation: implications from the DIONYSOS study.
    Pamukcu B, Lip GY.
    Expert Opin Pharmacother; 2010 Dec 29; 11(17):2775-8. PubMed ID: 21050033
    [Abstract] [Full Text] [Related]

  • 11. Dronedarone: current evidence and future questions.
    Schafer JA, Kjesbo NK, Gleason PP.
    Cardiovasc Ther; 2010 Dec 29; 28(1):38-47. PubMed ID: 20074258
    [Abstract] [Full Text] [Related]

  • 12. Dronedarone. atrial fibrillation: too many questions about long-term adverse effects.
    Prescrire Int; 2010 Aug 29; 19(108):149-52. PubMed ID: 20939439
    [Abstract] [Full Text] [Related]

  • 13. Dronedarone: a new antiarrhythmic agent for the treatment of atrial fibrillation.
    Garcia D, Cheng-Lai A.
    Cardiol Rev; 2009 Aug 29; 17(5):230-4. PubMed ID: 19690474
    [Abstract] [Full Text] [Related]

  • 14. Dronedarone: a review of characteristics and clinical data.
    Baroletti S, Catella J, Ehle M, Cheng JW.
    Crit Pathw Cardiol; 2010 Jun 29; 9(2):94-101. PubMed ID: 20520217
    [Abstract] [Full Text] [Related]

  • 15. Drug safety evaluation of dronedarone in atrial fibrillation.
    De Ferrari GM, Dusi V.
    Expert Opin Drug Saf; 2012 Nov 29; 11(6):1023-45. PubMed ID: 22971242
    [Abstract] [Full Text] [Related]

  • 16. Dronedarone: a novel antiarrhythmic agent for the treatment of atrial fibrillation.
    Duray GZ, Ehrlich JR, Hohnloser SH.
    Curr Opin Cardiol; 2010 Jan 29; 25(1):53-8. PubMed ID: 19881340
    [Abstract] [Full Text] [Related]

  • 17. Dronedarone in atrial fibrillation: the aftermath of the PALLAS trial.
    Salam AM.
    Expert Rev Cardiovasc Ther; 2012 Nov 29; 10(11):1345-9. PubMed ID: 23244355
    [Abstract] [Full Text] [Related]

  • 18. Dronedarone for the treatment of atrial fibrillation and atrial flutter.
    Maund E, McKenna C, Sarowar M, Fox D, Stevenson M, Pepper C, Palmer S, Woolacott N.
    Health Technol Assess; 2010 Oct 29; 14(Suppl. 2):55-62. PubMed ID: 21047492
    [Abstract] [Full Text] [Related]

  • 19. Dronedarone: an overview.
    Kozlowski D, Budrejko S, Lip GY, Mikhailidis DP, Rysz J, Raczak G, Banach M.
    Ann Med; 2012 Feb 29; 44(1):60-72. PubMed ID: 21745093
    [Abstract] [Full Text] [Related]

  • 20. Dronedarone: a promising alternative for the management of atrial fibrillation.
    Yalta K, Turgut OO, Yilmaz MB, Yilmaz A, Tandogan I.
    Cardiovasc Drugs Ther; 2009 Oct 29; 23(5):385-93. PubMed ID: 19669399
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.